CHAD BAUMAN: Open Payments
NPI 1588086078 · STEUBENVILLE, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$713 in 37 payments from 15 companies in 2025. Trend: 2023 $438 · 2024 $439 · 2025 $713
Food & beverage: $713
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $165 |
| AstraZeneca Pharmaceuticals LP | 7 | $117 |
| ABBVIE INC. | 4 | $64 |
| Lilly USA, LLC | 3 | $58 |
| GlaxoSmithKline, LLC. | 3 | $51 |
| Edwards Lifesciences Corporation | 1 | $46 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $40 |
| PFIZER INC. | 2 | $35 |
| Phathom Pharmaceuticals, Inc. | 1 | $27 |
| Dexcom, Inc. | 1 | $22 |
Products named: Ozempic, AIRSUPRA, VRAYLAR, MOUNJARO, TRELEGY ELLIPTA, JARDIANCE, BREZTRI, Wegovy.
Industry payments across OH — which companies pay providers there.
